Roth Keeps Verastem (VSTM) at Buy; Sees Positioned for 'Potentially Transformative Year'
Tweet Send to a Friend
Roth Capital reaffirms its Buy rating and $29 price target on Verastem (Nasdaq: VSTM) following recent quarterly/annual results.
Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
